WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 406455
Description: ER-805751 is a potent proteasome inhibitor.
MedKoo Cat#: 406455
Chemical Formula: C25H30N2O6
Exact Mass: 454.21039
Molecular Weight: 454.5155
Elemental Analysis: C, 66.06; H, 6.65; N, 6.16; O, 21.12
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: ER80575; ER-805751; ER 805751.
IUPAC/Chemical Name: N-((S)-3-hydroxy-1-(((S)-1-((S)-2-(hydroxymethyl)oxiran-2-yl)-4-methyl-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)-[1,1'-biphenyl]-3-carboxamide.
InChi Key: OBKFQHDCZCTNDS-WATLYSKOSA-N
InChi Code: InChI=1S/C25H30N2O6/c1-16(2)11-20(22(30)25(14-29)15-33-25)26-24(32)21(13-28)27-23(31)19-10-6-9-18(12-19)17-7-4-3-5-8-17/h3-10,12,16,20-21,28-29H,11,13-15H2,1-2H3,(H,26,32)(H,27,31)/t20-,21-,25-/m0/s1
SMILES Code: O=C(C1=CC(C2=CC=CC=C2)=CC=C1)N[C@@H](CO)C(N[C@@H](CC(C)C)C([C@@]3(CO)OC3)=O)=O
Appearance: white solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 454.5155 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1. Agoulnik, Sergei; Akasaka, Kozo; Fang, Frank; Harmange, Jean-Christophe; Hawkins, Lynn; Jiang, Yimin; Johannes, Charles; Li, Xiang-Yi; Mcguinness, Pamela; Murphy, Erin; et al. Preparation of eponemycin and epoxomicin analogs for pharmaceutical use. PCT Int. Appl. (2003), WO 2003059898 A2 20030724.